CX3CL1 and prostate carcinoma: Previous research has demonstrated that CX3CL1 plays a crucial function in numerous types of cancers, including ovarian carcinoma (Singh et al., 2019), B-cells lymphoma (Corcione et al., 2010), neuroblastoma (Nevo et al., 2009), breast cancer (Onitilo et al., 2009), gastric cancer (Lv et al., 2014), pancreatic cancer (Xu et al., 2012; Ran et al., 2020), prostate cancer (Tang et al., 2016), colorectal cancer (Zheng et al., 2013), lung cancer (Schmall et al., 2015), and hepatocellular cancer (Huang and Geng, 2010).